Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Lead Candidate (MIS416) Overview
CBRAIN: a web-based, distributed computing platform for collaborative neuroimaging research.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
Multiple sclerosis : A multielement survey.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery.
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
On the role of natural killer cells in neurodegenerative diseases.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
Identifying the amylome, proteins capable of forming amyloid-like fibrils.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
Osmotic demyelination syndrome in Intensive Care Unit.
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica.
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
[Vitamin D in Multiple Sclerosis].
Pages
« first
‹ previous
…
467
468
469
470
471
472
473
474
475
…
next ›
last »